SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy in men with HR PC
Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti-tumour activity
Considerations to make when communicating genomic information
Rationale for routine use of IORT for early breast cancer and data for specific indications
Single-dose IORT during lumpectomy for breast cancer an innovative patient-centred treatment
Global adoption of single-shot targeted IORT for breast cancer
IORT at the Asian Hospital and Medical Center
The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival
Insights from TARGIT-A trial of targeted IORT during lumpectomy for breast cancer
Choosing Wisely in radiology
Choosing Wisely in radiotherapy